Studying Gene Expression and Location in Samples From Patients With Brain Tumors - Trial NCT01585389
Access comprehensive clinical trial information for NCT01585389 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Oncology Group and is currently Completed. The study focuses on Brain and Central Nervous System Tumors. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Children's Oncology Group
Timeline & Enrollment
N/A
Apr 01, 2012
N/A
Primary Outcome
Correlation of NEIL3 expression and/or nuclear localization with tumor type or grade with respect to degree of differentiation
Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may
 help doctors identify and learn more about biomarkers related to brain tumors.
 
 PURPOSE: This research studies gene expression and location in samples from patients with
 brain tumors.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01585389
Non-Device Trial